Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Cell Reports
|
December 8, 2022
Cancer cell-derived type I interferons instruct tumor monocyte polarization
Dylan Kwart, Jing He, Subhashini Srivatsan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 7, 2013
Conditionals by inversion provide a universal method for the generation of conditional alleles
Aris N Economides, David Frendewey, Peter Yang, et al.
Science Translational Medicine
|
November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
Christopher D Petro, Andrea T Hooper, Avery Peace, et al.
Science Translational Medicine
|
January 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
Dimitris Skokos, Janelle C Waite, Lauric Haber, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Cell Reports
|
December 8, 2022
Cancer cell-derived type I interferons instruct tumor monocyte polarization
Dylan Kwart, Jing He, Subhashini Srivatsan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 7, 2013
Conditionals by inversion provide a universal method for the generation of conditional alleles
Aris N Economides, David Frendewey, Peter Yang, et al.
Science Translational Medicine
|
November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
Christopher D Petro, Andrea T Hooper, Avery Peace, et al.
Science Translational Medicine
|
January 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
Dimitris Skokos, Janelle C Waite, Lauric Haber, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 4